Clinical Trial Update: Systemic Pharmacokinetics of BOL-303224-A [Phase 1]

View source ↗

Summary

Phase 1 trial update reports systemic pharmacokinetics data for BOL-303224-A in bacterial conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• BOL-303224-A

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Conjunctivitis, Bacterial | Phase 1 | Status: COMPLETED